Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs.
about
Outcome after discontinuation of nucleot(s)ide analogues in chronic hepatitis B: relapse rate and associated factorsIncidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL.The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis.Hepatitis B surface antigen levels of cessation of nucleos(t)ide analogs associated with virological relapse in hepatitis B surface antigen-negative chronic hepatitis B patientsStudy on Post-Treatment Relapse in HBeAg Positive CHB Patients.HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients.Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy.5-year efficacy of entecavir in Indian patients with chronic hepatitis B.Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg.Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis.Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
P2860
Q27020938-84660C40-66EA-4107-A78A-72694E876ADDQ33686951-5B8EA47A-F4AD-40FE-9DA0-A9CDF0D85AB0Q35726960-8BF15FAA-89C9-462E-9F9C-5000CFEEC52EQ35891425-1AD53938-E2B6-42B0-B7AA-CF49F53ECE9BQ36239764-320DECBC-EFC7-44BA-8290-A9BE60A7C497Q38295840-E0933E69-A9B2-4CD3-A6F8-835A3A2E3640Q38543596-E71FBB78-2F8E-4ED1-B52A-0F372990D0CBQ40361006-84116477-9D10-4854-BAB1-74BD56346CAAQ40739807-AE964AC4-C4A7-48AD-839A-D99520C7CCF8Q40817492-82749414-2AC0-4C64-8E26-CDE6C7FC8F56Q42121506-E2EA3B74-E23C-4975-A6D4-A71C5B74320BQ54217690-3170F40C-967F-4BA7-97DC-B075634A6BB7
P2860
Off-treatment virologic relapse and outcomes of re-treatment in chronic hepatitis B patients who achieved complete viral suppression with oral nucleos(t)ide analogs.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Off-treatment virologic relaps ...... suppression with oral nucleos
@nl
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@ast
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@en
type
label
Off-treatment virologic relaps ...... suppression with oral nucleos
@nl
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@ast
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@en
prefLabel
Off-treatment virologic relaps ...... suppression with oral nucleos
@nl
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@ast
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@en
P2093
P2860
P356
P1476
Off-treatment virologic relaps ...... th oral nucleos(t)ide analogs.
@en
P2093
Bo Young Min
Cheol Min Shin
Dong Ho Lee
Eun Sun Jang
Hyung Rae Sohn
Jin-Hyeok Hwang
Jin-Wook Kim
Joon Chang Song
Mun Hyuk Seong
Sang Soo Lee
P2860
P2888
P356
10.1186/1471-2334-14-439
P50
P577
2014-08-13T00:00:00Z
P5875
P6179
1040190851